Given the accelerated role of ZDHHC3 in regulating IRHOM2 signal, the above obtained in vivo and in vitro results forced us to study another critical concern, whether and how ZDHHC3 interacted with IRHOM2 in the setting of NASH. Here, RHBDF2 is linked to metabolic dysfunction-associated steatohepatitis.